MyAverix Finance
HK · Healthcare
Hangzhou Tigermed Consulting Co Ltd (3347)
Diagnostics & Research
Hangzhou Tigermed Consulting Co Ltd (3347) is listed on HK in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-21, reported market cap is $27.90B, P/E ratio is 30.86, net margin is 10.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3347
Hangzhou Tigermed Consulting Co Ltd (3347) — FAQ
What is Hangzhou Tigermed Consulting Co Ltd's market cap?
Hangzhou Tigermed Consulting Co Ltd (3347) has a reported market cap of $27.90B (data as of 2026-05-21).
What is 3347's P/E ratio?
The price-to-earnings (P/E) ratio for Hangzhou Tigermed Consulting Co Ltd (3347) is 30.86 (data as of 2026-05-21).
Does Hangzhou Tigermed Consulting Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hangzhou Tigermed Consulting Co Ltd (3347). Check the MyAverix Finance app for the latest dividend data.
What sector is Hangzhou Tigermed Consulting Co Ltd in?
Hangzhou Tigermed Consulting Co Ltd (3347) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 3347 listed on?
3347 is listed on HK.
What is Hangzhou Tigermed Consulting Co Ltd's net margin?
Hangzhou Tigermed Consulting Co Ltd (3347) reports a net margin of 10.9% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.